The deeper threat to the biopharmaceutical industry may come not from macro-level disruption, but from structural pressures ...
How AI and other digital tools are progressing across the bio/pharmaceutical industry is on top of mind. Key perspectives on ...
Merck KGaA has agreed to acquire Silence Therapeutics, a Cambridge, UK-based clinical-stage bio/pharmaceutical company developing short interfering RNA (siRNA) medicines, for $1.3 billion, ...
Sanofi has broken ground on a new insulin manufacturing facility in Frankfurt, Germany. The new facility will be built on a 36,000-square-meter footprint at the Sanofi BioCampus in Frankfurt.
The Board of Directors of CSL, a Melbourne, Australia-based bio/pharmaceutical company, has appointed Deborah Waterhouse, currently Chief Executive Officer (CEO) of ViiV Healthcare, a joint venture ...
A recent KPMG study of more than 1,300 CEOs at large companies globally, including 400 US companies, say supply-chain cost ...
What are key trends for injectable drugs and the related market impact? From switches from IV-administered to subcutaneous ...
Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view all ...
The US Food and Drug Administration (FDA) is moving forward with a pilot program in which the agency is seeing to reduce the agency’s drug review times for standard review to 1 to 2 months for certain ...
In looking at the news developments from the CDMO market in 2026, certain themes emerge. The blockbuster success of the glucagon-like peptide-1 (GLP-1) receptor agonists for treating obesity and Type ...
Deal-making among the large bio/pharmaceutical companies and smaller companies is an important source of product innovation in the industry. The deals are important for seeing what pipeline contenders ...
In terms of rising stars among small-molecule drugs, a key entry is Eli Lilly and Company’s oral obesity drug, Foundayo (orforglipron), a once-daily small-molecule (non-peptide) oral glucagon-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results